Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP2C9 haplotype structure in European American warfarin patients and association with clinical outcomes.

Clinical pharmacology and therapeutics - 1 May 2005

Veenstra David L, Blough David K, Higashi Mitchell K, Farin Frederico M, Srinouanprachan Sengkeo, Rieder Mark J, Rettie Allan E

Abstract excerpt

OBJECTIVE: The goal of this study was to define the haplotype structure of the cytochrome P450 (CYP) 2C9 gene in a European American population and evaluate associations between CYP2C9 haplotypes and anticoagulation-related outcomes. METHODS: Genomic deoxyribonucleic acid from 192 European American patients stabilized on warfarin therapy was resequenced across 60 kilobases of the CYP2C9 genomic region, including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Family Health

Share to Sequence Analysis

Share to Treatment Outcome

Share to Warfarin

Share to White People

Source

Identifiers

PMID: 15900281
DOI: 10.1016/j.clpt.2005.01.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP2C9 haplotype structure in European American warfarin patients and association with clinical outcomes.PMID 15900281Read ↗

Global variation in CYP2C8-CYP2C9 functional haplotypes.Semantic proximity Read ↗

Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin.Semantic proximity Read ↗

PharmVar GeneFocus: CYP2C9.Semantic proximity Read ↗

Pharmacogenomics of CYP2C9: Functional and Clinical ConsiderationsSemantic proximity Read ↗

A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China.Semantic proximity Read ↗

Global distribution of functionally important CYP2C9 alleles and their inferred metabolic consequences.Semantic proximity Read ↗

PharmVar GeneFocus: CYP2C19.Semantic proximity Read ↗

CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.Semantic proximity Read ↗

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis.Semantic proximity Read ↗

The bleeding risk during warfarin therapy is associated with the number of variant alleles of CYP2C9 and VKORC1 genes.Semantic proximity Read ↗

Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX.Semantic proximity Read ↗

<i>VKORC1</i> Polymorphisms, Haplotypes and Haplotype Groups on Warfarin Dose Among African–Americans and European–AmericansSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.